We have been awarded the EcoVadis Gold Star Rating for sustainability efforts, which places us among the top 5% globally for sustainability performance and the top 2% in our industry out of the 75,000 companies assessed across 160 countries and 200 industries . This award is a testament to not only our dedication to making a positive impact on humanity through the applications of our genomics technologies, but also through how we operate.
A study we co-authored out today in JAMA Pediatrics supports the widespread adoption and implementation of #WGS for #newborns in crisis.
At ESMO Congress 2021, we welcomed speakers Dr. Henrik Hager and Prof. Ed Schuuring to discuss comprehensive genomic profiling for NSCLC. #ESMO #ESMO2021
Yesterday, we launched iLatinx, a new employee resource group. iLatinx will support Latinx-identified employees, create forums to educate employees about Latinx cultures and issues, and provide leadership development opportunities for Latinx employees. Read more about the ways we foster an inclusive, flexible environment for our employees. #HispanicHeritageMonth #HispanicHeritage #Latinx #EmployeeResourceGroup
Illumina supports #COVID surveillance in more than 70 countries. From delivering instruments to developing COVIDSeq, we have lived out our core value to “move fast and embrace change.”
Every year, we provide our employees with a Health and Lifestyle Allowance (HLA), aiming to encourage employees to embrace their creativity outside the workplace. Lisa R., a Clinical Lab Technician 3, used her creativity to take on the challenge of building a 9’2” longboard by hand in her garage. After a few months’ worth of glassing and sanding, Lisa finally sees the end in sight and is eager to take her new creation out for its maiden surfing voyage on the Pacific. #surfing #surfboard #longboard #creativity
Francis deSouza reflects on the impact early detection of cancer will have on saving lives and how the GRAIL, Inc. acquisition fulfills Illumina’s mission. Listen on Apple Podcasts.
“We’re fortunate to have Susan and Alex, two of the strongest leaders in the genomics industry, take on these large, important roles.” - Francis deSouza, Chief Executive Officer of Illumina. We are happy to share Susan Tousi will become Illumina’s Chief Commercial Officer, and Alex Aravanis, MD, PhD, will become Chief Technology Officer, Head of Research and Product Development.
We are thrilled to be included in the inaugural TIME100 Most Influential Companies list! #TIME100Companies
We have been included in two prestigious lists that recognize organizations demonstrating leadership in diversity and inclusion: Bloomberg LP Gender Equality Index (GEI) and the Human Rights Campaign Corporate Equality Index (CEI). We are inspired that our diversity, inclusion and fairness initiative continues to build opportunities to strengthen the relationship between our employees, our company and our communities. #CEI2021 #BloombergGEI
